Our study first elucidated the circMAPK9/miR-140-3p/PPM1A regulatory network in RA-FLSs, offering a new perception about RA-FLSs progression, and offering a novel possible target for RA therapy. This evidence concerns the gene PPM1A and rheumatoid arthritis.